MENQUADFI
MENQUADFI
Approved
DIN Number
02507161
Drug Class
Human
Market Date
Apr 1, 2025
Company
HC
Sanofi Pasteur Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02507161
AIG Number0562558001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07AH08 MENINGOCOCCUS, A, C, Y, W-135, TETRAVAL. PURIFIED POLYSACC. ANTIGEN CONJUGATED
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (5)
MENINGOCOCCAL GROUP A POLYSACCHARIDE-TETANUS TOXOID CONJUGATEActive
Strength: 10 MCG / 0.5 ML
Monograph: MENINGOCOCCAL GROUP A POLYSACCHARIDE-TETANUS TOXOID CONJUGATE
MENINGOCOCCAL GROUP C POLYSACCHARIDE-TETANUS TOXOID CONJUGATEActive
Strength: 10 MCG / 0.5 ML
Monograph: MENINGOCOCCAL GROUP C POLYSACCHARIDE-TETANUS TOXOID CONJUGATE
MENINGOCOCCAL GROUP W POLYSACCHARIDE-TETANUS TOXOID CONJUGATEActive
Strength: 10 MCG / 0.5 ML
Monograph: MENINGOCOCCAL GROUP W POLYSACCHARIDE-TETANUS TOXOID CONJUGATE
MENINGOCOCCAL GROUP Y POLYSACCHARIDE-TETANUS TOXOID CONJUGATEActive
Strength: 10 MCG / 0.5 ML
Monograph: MENINGOCOCCAL GROUP Y POLYSACCHARIDE-TETANUS TOXOID CONJUGATE
TETANUS TOXOIDActive
Strength: 55 MCG / 0.5 ML
Monograph: TETANUS TOXOID